Cargando…

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies

BACKGROUND: Hepatocellular carcinoma is a major health problem worldwide and the third most common cause of cancer-related death. HCC treatment decisions are complex and dependent upon tumor staging. Several molecular targeted agents have been evaluated in clinical trials in advanced HCC. Despite of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertino, Gaetano, Demma, Shirin, Ardiri, Annalisa, Proiti, Maria, Malaguarnera, Giulia, Bertino, Nicoletta, Malaguarnera, Mariano, Malaguarnera, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393929/ https://www.ncbi.nlm.nih.gov/pubmed/25893197 http://dx.doi.org/10.1155/2015/731469

Ejemplares similares

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: Bertino, Gaetano, et al.
Publicado: (2014)

Rare Benign Tumors of the Liver: Still Rare?
por: Bertino, Gaetano, et al.
Publicado: (2014)

Serum Folate deficiency in HCV related Hepatocellular Carcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2022)

Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
por: Bertino, Gaetano, et al.
Publicado: (2018)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Elevated serum levels of Chromogranin A in hepatocellular carcinoma
por: Biondi, Antonio, et al.
Publicado: (2012)

Carbohydrate 19.9 Antigen Serum Levels in Liver Disease
por: Bertino, Gaetano, et al.
Publicado: (2013)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Michele, et al.
Publicado: (2018)

Carnitine Serum Levels in Frail Older Subjects
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial
por: Malaguarnera, Giulia, et al.
Publicado: (2014)

Potential role of probiotics on colorectal cancer prevention
por: Uccello, Mario, et al.
Publicado: (2012)

High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Risk of Hepatocellular Carcinoma in Workers Exposed to Chemicals
por: Uccello, Mario, et al.
Publicado: (2012)

Resveratrol in Patients with Minimal Hepatic Encephalopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2018)

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
por: Pennisi, Manuela, et al.
Publicado: (2017)

Anorectal mucosal melanoma
por: Malaguarnera, Giulia, et al.
Publicado: (2018)

Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients
por: Malaguarnera, Michele, et al.
Publicado: (2011)

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
por: Malaguarnera, Giulia, et al.
Publicado: (2016)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Carnitine derivatives beyond fatigue: an update
por: Malaguarnera, Michele, et al.
Publicado: (2023)

Neurotoxicity of Acrylamide in Exposed Workers
por: Pennisi, Manuela, et al.
Publicado: (2013)

Influence of Resveratrol on the Immune Response
por: Malaguarnera, Lucia
Publicado: (2019)

Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
por: Cammalleri, Lisa, et al.
Publicado: (2007)

Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
por: Uccello, Mario, et al.
Publicado: (2011)

A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
por: Toro, Adriana, et al.
Publicado: (2015)

Tumor lysis syndrome in an extraskeletal osteosarcoma: a case report and review of the literature
por: Catania, Vito Emanuele, et al.
Publicado: (2017)

Vitamin D3 as Potential Treatment Adjuncts for COVID-19
por: Malaguarnera, Lucia
Publicado: (2020)

Lipoprotein(a) in Cardiovascular Diseases
por: Malaguarnera, Michele, et al.
Publicado: (2013)

Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain
por: Pennisi, Manuela, et al.
Publicado: (2019)

Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature
por: Di Carlo, Isidoro, et al.
Publicado: (2012)

Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications?
por: Toro, Adriana, et al.
Publicado: (2015)

Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies
por: Malaguarnera, Michele, et al.
Publicado: (2019)

Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study
por: Toro, Adriana, et al.
Publicado: (2014)

The Insulin Receptor: A New Target for Cancer Therapy
por: Malaguarnera, Roberta, et al.
Publicado: (2011)

Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016)

The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
por: Vella, Veronica, et al.
Publicado: (2018)

Comparison of Vitamin D and Resveratrol Performances in COVID-19
por: Russo, Cristina, et al.
Publicado: (2023)

Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome
por: Vicari, Enzo, et al.
Publicado: (2017)

Depression in older breast cancer survivors
por: Frazzetto, Paola, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gjpbu4gfpsbqddn1e0s0v6g2d2